Delivery Order SPE2DB24D2213-SPE2DB25FGWBE
Award Date
3/4/25
Potential Completion Date
3/5/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,968.12, is for the delivery of 4567445266 letrozole 2.5 mg tablets in 90-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of March 4, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a $3,118.24 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,565,845,253 tablets of the drug Letrozole 2.5 mg to support military treatment programs and facilities. This award is not designated as a set-aside contract. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of 4,566,403,935 tablets of the drug Letrozole 2.5 mg. The $14,750.91 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of November 13, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Letrozole 2.5 mg tablets to the Defense Logistics Agency (DLA). The $9,097.28 firm fixed-price delivery order has a completion date of February 27, 2025. The contract is not designated as a set-aside and is issued under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Letrozole 2.5 mg tablets. The $4,972.14 firm fixed-price delivery order has an ultimate completion date of October 17, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, identified as SPE2DB20D2001|SPE2DB25FPMBB, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,440.50 firm-fixed-price delivery order is for the supply of 90-count bottles of the medication Letrozole 2.5 mg tablets. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPT44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,081.74 firm-fixed-price delivery order contract is for the supply of Letrozole 2.5 mg tablets, a medication used in the treatment of certain types of breast cancer. The contract, which has an ultimate completion date of March 4, 2025, is not designated as a set-aside....
This federal contract award is for the delivery of Letrozole 2.5 mg tablet (90 count) to the Defense Logistics Agency (DLA), a major procurement agency within the U.S. Department of Defense (DoD). The contract, valued at $9,446.84, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract does not have a set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's...
Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $9,147.62 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to supply 90 count bottles of 2.5 mg Letrozole tablets. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 30th to August 31st, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the United States armed forces through...
The U.S. government's Defense Logistics Agency (DLA) awarded a $2,387.58 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply a variety of medical products. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...